FMP
Pear Therapeutics, Inc.
PEAR
NASDAQ
Inactive Equity
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal, oncology, and cardiovascular. Pear Therapeutics, Inc. was incorporated in 2013 and is based in Boston, Massachusetts.
0.0292 USD
0 (0%)
About
ceo
Mr. Christopher D. T. Guiffre J.D., M.B.A., MBA
sector
Healthcare
industry
Medical - Healthcare Information Services
website
https://peartherapeutics.com
exchange
NASDAQ
Description
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal, oncology, and cardiovascular. Pear Therapeutics, Inc. was incorporated in 2013 and is based in Boston, Massachusetts.
CIK
0001835567
ISIN
US7047231052
CUSIP
704723105
Address
200 State Street
Phone
617 925 7848
Country
US
Employee
200
IPO Date
Mar 31, 2021
Summary
CIK
0001835567
Exchange
NASDAQ
Industry
Medical - Healthcare...
Sector
Healthcare
CUSIP
704723105
ISIN
US7047231052
Country
US
Price
0.03
Beta
0.52
Volume Avg.
10.09M
Market Cap
4.09M
Shares
-
52-Week
0.009-6.74
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.08
P/B
-
Website
https://peartherapeutics.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest PEAR News
It looks like there's no news available.
